: Assesses for hematuria and baseline kidney function metrics.
Spindle-cell stroma, which may contain heterologous elements like skeletal muscle, cartilage, or fat. Clinical Classification (The Prognostic Pivot)
Should we add specific for the imaging slide?
Based on surgical and histopathological findings prior to chemotherapy.
: Residual non-hematogenous tumor present in the abdomen (e.g., lymph node involvement or tumor rupture). wilms tumor ppt new
: Abdominal ultrasounds and chest radiographs every 3 months for the first 2 years post-treatment.
: Microscopic or macroscopic blood in urine occurs in 25% of cases.
: Initial screening tool to confirm renal origin and assess the inferior vena cava (IVC).
Monitored via GFR and blood pressure checks; risk increases significantly in syndromic patients or those undergoing bilateral resections. : Assesses for hematuria and baseline kidney function
The initial screening tool. Confirms a renal origin, evaluates the contralateral kidney, and assesses the patency of the renal vein and Inferior Vena Cava (IVC) to rule out tumor thrombus.
: Wilms’ tumor, Aniridia, Genitourinary anomalies, and intellectual disability (11p13 deletion).
: Regular assessment of GFR, blood pressure, and urinalysis to watch for chronic kidney disease.
Wilms tumor (nephroblastoma) is the most common primary renal malignancy in children, accounting for approximately 90% of pediatric kidney cancers. While historical outcomes were once poor, modern multi-modal treatment strategies—coordinated by major international bodies like the Children's Oncology Group (COG) and the International Society of Pediatric Oncology (SIOP)—have elevated the overall five-year survival rate to over 90%. Current research is shifting focus from merely achieving a cure to reducing the long-term toxicity of treatment and identifying molecular markers that can predict outcomes for high-risk subgroups, such as those with diffuse anaplastic histology. Genetic Basis and Pathogenesis Based on surgical and histopathological findings prior to
Distant hematogenous metastases present (e.g., lungs, liver, bone, brain).
Wilms tumor, or nephroblastoma, is the most common primary renal malignancy in children. It accounts for approximately 90% of all pediatric kidney tumors and 7% of all childhood cancers. This comprehensive clinical guide is structured to serve as an exhaustive resource for medical professionals, residents, and students. It is optimized for presentation format (PPT), integrating current clinical data, staging updates, and molecular insights. 1. Epidemiology and Demographics
This structured outline for a "Wilms Tumor" (Nephroblastoma) presentation incorporates the latest clinical guidelines and staging systems (COG vs. SIOP) as of 2026. Definition : A malignant embryonal tumor of the kidney. Epidemiology :
To create a comprehensive and modern PowerPoint (PPT) on Wilms Tumor
: Assesses for hematuria and baseline kidney function metrics.
Spindle-cell stroma, which may contain heterologous elements like skeletal muscle, cartilage, or fat. Clinical Classification (The Prognostic Pivot)
Should we add specific for the imaging slide?
Based on surgical and histopathological findings prior to chemotherapy.
: Residual non-hematogenous tumor present in the abdomen (e.g., lymph node involvement or tumor rupture).
: Abdominal ultrasounds and chest radiographs every 3 months for the first 2 years post-treatment.
: Microscopic or macroscopic blood in urine occurs in 25% of cases.
: Initial screening tool to confirm renal origin and assess the inferior vena cava (IVC).
Monitored via GFR and blood pressure checks; risk increases significantly in syndromic patients or those undergoing bilateral resections.
The initial screening tool. Confirms a renal origin, evaluates the contralateral kidney, and assesses the patency of the renal vein and Inferior Vena Cava (IVC) to rule out tumor thrombus.
: Wilms’ tumor, Aniridia, Genitourinary anomalies, and intellectual disability (11p13 deletion).
: Regular assessment of GFR, blood pressure, and urinalysis to watch for chronic kidney disease.
Wilms tumor (nephroblastoma) is the most common primary renal malignancy in children, accounting for approximately 90% of pediatric kidney cancers. While historical outcomes were once poor, modern multi-modal treatment strategies—coordinated by major international bodies like the Children's Oncology Group (COG) and the International Society of Pediatric Oncology (SIOP)—have elevated the overall five-year survival rate to over 90%. Current research is shifting focus from merely achieving a cure to reducing the long-term toxicity of treatment and identifying molecular markers that can predict outcomes for high-risk subgroups, such as those with diffuse anaplastic histology. Genetic Basis and Pathogenesis
Distant hematogenous metastases present (e.g., lungs, liver, bone, brain).
Wilms tumor, or nephroblastoma, is the most common primary renal malignancy in children. It accounts for approximately 90% of all pediatric kidney tumors and 7% of all childhood cancers. This comprehensive clinical guide is structured to serve as an exhaustive resource for medical professionals, residents, and students. It is optimized for presentation format (PPT), integrating current clinical data, staging updates, and molecular insights. 1. Epidemiology and Demographics
This structured outline for a "Wilms Tumor" (Nephroblastoma) presentation incorporates the latest clinical guidelines and staging systems (COG vs. SIOP) as of 2026. Definition : A malignant embryonal tumor of the kidney. Epidemiology :
To create a comprehensive and modern PowerPoint (PPT) on Wilms Tumor
The Noble Lighthouse. All rights reserved. © 2026
